NIDCR Requests Input on Proposed Research Initiatives
NIDCR Home | Careers | Contact
Announcements
The National Institute of Dental and Craniofacial Research (NIDCR) requests your input on six proposed concepts (research initiatives) presented at the September 2022 National Advisory Dental and Craniofacial Research Council meeting. The six initiatives are listed below. To read the full initiative descriptions and provide input, please visit: NIDCR Requests Input on FY 2023 Proposed Research Initiatives
Initiatives:
...
Source: NIDCR Science News - October 6, 2022 Category: Dentistry Source Type: news
Total Number of HPV Vaccination Encounters Down During Pandemic
FRIDAY, Sept. 23, 2022 -- There was an increase in human papillomavirus (HPV) vaccination per encounter for pediatric patients aged 9 to 22 years, despite a decrease in overall encounters associated with the COVID-19 pandemic, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 23, 2022 Category: Pharmaceuticals Source Type: news
HPV Vaccination, Infection Rates Examined in U.S. Women
TUESDAY, Aug. 23, 2022 -- Human papillomavirus (HPV) vaccination appears to be associated with a reduction in HPV-16/18 infection prevalence among a recent birth cohort of vaccinated and unvaccinated 18- to 26-year-old women, according to a research... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 23, 2022 Category: Pharmaceuticals Source Type: news
Vaccines Have Slashed Rates of HPV Infection in Young American Women
MONDAY, Aug. 22, 2022 -- Back in 2006, doctors began recommending the first vaccine for the common sexually transmitted human papillomavirus (HPV), with the shots carrying the potential to lower the risk of certain cancers.
Now, a new study shows... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 22, 2022 Category: General Medicine Source Type: news
Cases of Advanced Cervical Cancer Keep Rising Among U.S. Women
FRIDAY, Aug. 19, 2022 -- New research points to a conundrum with cervical cancer: While rates of early-stage disease have been dropping in the United States ever since the human papillomavirus (HPV) vaccine was introduced, advanced cases have been... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 19, 2022 Category: General Medicine Source Type: news
HPV Vaccination May Cut Risk for CIN2+ Recurrence
FRIDAY, Aug. 5, 2022 -- Human papillomavirus (HPV) vaccination seems to reduce the risk for cervical intraepithelial neoplasia grade 2 or higher (CIN2+) recurrence, according to a review published online Aug. 3 in The BMJ.
Konstantinos S.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 5, 2022 Category: Pharmaceuticals Source Type: news
When Treating Cervical Lesions, Adding HPV Vaccine Could Further Curb Cancer Risk
FRIDAY, Aug. 5, 2022 -- Most sexually active people will contract the human papillomavirus (HPV) during their lifetimes, and about 90% will clear it from their bodies. But some women are susceptible to the cervical lesions that infection brings,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 5, 2022 Category: General Medicine Source Type: news
HPV Vaccination Close to Surgery May Reduce Recurrent Cervical Lesions
(MedPage Today) -- Vaccination for human papillomavirus (HPV) near the time of surgery for precancerous cervical lesions significantly reduced the rate of lesion recurrence, a meta-analysis showed.
Overall, vaccination reduced the risk of recurrent... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 4, 2022 Category: Hematology Source Type: news
HPV vaccine after removal of precancerous cells may cut cervical cancer risk
Study finds reduced risk of cervical cancer recurring after HPV vaccination post-surgery, though further research is neededGiving women the human papillomavirus (HPV) vaccine when precancerous lesions are removed from their cervix may cut the risk of cells recurring and them getting cervical cancer, a study has found.Cases of cervical cancerin the UK have fallen hugely since school pupils aged 13 and 14 – first girls and later boys – began being offered HPV jabs in 2008 as protection against the disease.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - August 3, 2022 Category: Science Authors: Denis Campbell Health policy editor Tags: Health Cervical cancer HPV vaccine Vaccines and immunisation Women Women's health UK news Cancer research Medical research Source Type: news
Single Dose of HPV Vaccine Is'Game Changer,' Says WHO Single Dose of HPV Vaccine Is'Game Changer,' Says WHO
The World Health Organization (WHO) says that a single dose of vaccine against human papillomavirus (HPV) delivers solid protection, comparable to that with two-dose schedules.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 27, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche achieves good results in the first six months of 2022
Group sales up 5%1 at constant exchange rates (CER) and 5% in Swiss francsPharmaceuticals Divisionsales increase 3%; continued strong demand for new medicines to treat severe diseases; as expected, the impact of biosimilars slows down furtherDiagnostics Divisionsales grow 11%; ongoing strong base business; demand for COVID-19 tests is expected to decline in the second half of the yearIFRSnet income increases by 12% (12% in Swiss francs), whilecore earnings per share are up 11%Highlights in the second quarter:EU approvals ofPolivy (first-line treatment for aggressive form of blood cancer),Lunsumio (follicular lymphoma) andT...
Source: Roche Investor Update - July 21, 2022 Category: Pharmaceuticals Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche achieves good results in the first six months of 2022
Basel, 21 July 2022Group sales up 5%1 at constant exchange rates (CER) and 5% in Swiss francsPharmaceuticals Divisionsales increase 3%; continued strong demand for new medicines to treat severe diseases; as expected, the impact of biosimilars slows down furtherDiagnostics Divisionsales grow 11%; ongoing strong base business; demand for COVID-19 tests is expected to decline in the second half of the yearIFRSnet income increases by 12% (12% in Swiss francs), whilecore earnings per share are up 11%Highlights in the second quarter:EU approvals ofPolivy (first-line treatment for aggressive form of blood cancer),Lunsumio (follic...
Source: Roche Media News - July 21, 2022 Category: Pharmaceuticals Source Type: news
Thousands report unusual menstruation patterns after COVID-19 vaccination
Kathryn Clancy got her first dose of a COVID-19 vaccine in early 2021 and 10 days later found herself sitting uncomfortably in a work Zoom meeting during one of the heaviest periods she’d experienced. “I had what’s often called menstrual flooding,” says Clancy, a biological anthropologist at the University of Illinois, Urbana-Champaign. Clancy wouldn’t have thought to connect the experience to the Moderna dose she’d received were it not for her graduate student, Katharine Lee, now at Tulane University, who shared a similar tale. “I had the worst cramps of my life” after COVID-19 vaccination, Lee says. Intri...
Source: ScienceNOW - July 15, 2022 Category: Science Source Type: news
HPV-Related Throat Cancer Outcomes in Men Vary by Race, Ethnicity
FRIDAY, July 15, 2022 -- Non-Hispanic White men are disproportionately affected by late-stage human papillomavirus (HPV)-related oropharyngeal cancer (OPC), but cancer-specific mortality (CSM) is elevated among Hispanic and non-Hispanic Black men,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 15, 2022 Category: Pharmaceuticals Source Type: news
2015 to 2020 Saw Increase in HPV Vaccination Rates Among Teens
FRIDAY, June 24, 2022 -- Human papillomavirus (HPV) vaccination coverage increased among adolescents from 2015 to 2020, with a larger increase seen among boys, according to a study published online June 22 in Pediatrics.
Peng-jun Lu, M.D., Ph.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 24, 2022 Category: Pharmaceuticals Source Type: news
